Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
Premature birth needs to be in specialist centres - study
Thurs October 17th - Women facing premature labour should be enabled to give birth in hospitals with specialist neonatal intensive care units, researchers say today. More
How GPs can respond to private gene test results
Thurs October 17th - Doctors confronted by patients armed with the results of private gene testing should check for family genetic history that might support the claimed results, according to experts today. More
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote: on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
On 12/03/2017 Steph wrote:
The photo you have paired with this article is its... on 'Fat shaming' limits...
Clearing the air: An Assessment of Asthma and Indoor Allergens ABC of Asthma For more books click here
RSS graphic XML Graphic

Oral steroid warning for asthma patients

Wednesday October 2nd, 2019

Too many people with severe asthma are at risk through the use of oral steroids, a major European conference will hear today.

An observational study was carried out by Dr Katrien Eger and her team at Amsterdam University in The Netherlands. They analysed a pharmacy database of 500,500 Dutch people and found 5,002 people with asthma who were taking 500 micrograms or more a day of inhaled corticosteroids and long-acting beta agonists.

Questionnaires were sent to these patients and 2,312 were returned. Findings are presented today (2 October) at the European Respiratory Society International Congress in Madrid, Spain.

Analysis showed that a third of patients were taking harmful doses of oral steroids. It also suggested that most of these patients could avoid taking oral steroids by improving their adherence to their other asthma medication and their inhaler technique.

In addition, the researchers found that many patients who might be eligible for treatment with new biologic asthma drugs are not yet receiving them.

Dr Eger said: “Asthma patients using high doses of oral steroids are at risk of serious adverse effects such as diabetes, osteoporosis and adrenal insufficiency, in which the adrenal glands do not produce adequate amounts of steroid hormones.

“Our findings show that many patients with severe asthma are taking harmfully high doses of oral steroids. Every prescription for oral steroids should alert doctors to assess adherence to inhaled therapies and inhalation techniques in these patients.

“Furthermore, now that there is an increasing number of biologic asthma drugs available that avoid the need for oral steroids, doctors should initiate biologic treatment in suitable patients to reduce exposure to harmful oral steroids.”

Abstract no: OA5334, “Overuse of oral corticosteroids in asthma – modifiable factors and potential role of biologics”, by Katrien A.B. Eger et al is presented on Wednesday 2 October 2019 at the European Respiratory Society International Congress in Madrid, Spain, from 28 September to 2 October 2019.

Tags: Allergies & Asthma | Europe | Pharmaceuticals

Printer friendly page Printer friendly page

Comment on this article:

<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)